PCRX (Pacira BioSciences) Earnings per share growth rate in current year
The implementation of automated filling lines for liposomal solutions opens new horizons for efficiency for Pacira BioSciences (PCRX). Relative EPS YoY dynamics demonstrate current profitability trends, where the latest parameter stands at 9.20. Entry into the veterinary market and global growth ensure business stability. High surgeon confidence in the Exparel brand confirms its status as a leader in creating safe alternatives to opioids.
Financial and market metric breakdowns for Pacira BioSciences (PCRX)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt and liquidity details:
- net income and valuation multiples indicators:
PCRX - Net Income|Expected Net Income Pacira BioSciences|PCRX - P/E Multiple|Future Price to Earnings Pacira Corp|PCRX - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Pacira Corp|PCRX - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Pacira BioSciences|PCRX - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months pacira.com|PCRX - Earnings growth in current year|Expected earnings per share growth for next year Pacira BioSciences
Fundamental valuation:PCRX - Pacira Pharmaceuticals
This metric measures the annual dynamics of net income per share, reflecting the rate of change in the business's fundamental value through the percentage deviation of current results from the previous year. For Pacira BioSciences (PCRX), this indicator links financial efficiency to the costs of implementing biodegradable packaging and energy saving, allowing for an assessment of the ESG transformation's impact on profitability via the relative EPS YoY trend.
Main competitors
Haleon PLC - Earnings per share increase in current year|KVUE (Kenvue Corp) - Earnings growth in current year|Earnings per share growth rate in current year Verona Pharma Inc. VRNA|Earnings per share growth in current year Jyong Biotech Ltd (MENS)|LGND (ligand.com) - Earnings per share increase in current year|Earnings per share growth in current year Amneal AMRX|PRGO (Perrigo Company PLC) - Earnings per share trend in current year|Alvotech Corp - Earnings growth in current year|LQDA - Earnings growth in current year|GLPG: Earnings growth in current year|Net earnings per share growth this year anipharmaceuticals.com|MNKD (MannKind) - Earnings growth in current year|Amphastar Pharmaceuticals Inc (AMPH) - Expected net earnings per share growth this year|Earnings per share growth in current year ARS Pharma (SPRY)|TBPH (Theravance Corp) - Earnings per share increase in current year|Earnings growth in current year AQST (Aquestive Therapeutics)|Earnings growth in current year scPharmaceuticals, Inc. SCPH|TECX: Net earnings per share growth this year|Earnings per share increase in current year TNXP (Tonix Pharma)|SXTC: Earnings growth in current year|EPRX (Eupraxia Pharmaceuticals Inc.) - Earnings per share growth in current year|BHST (BioHarvest Sciences) - Earnings growth in current year|invizyne.com (EXOZ) - Expected net earnings per share growth this year|Earnings per share growth in current year Oramed Pharmaceuticals (ORMP)|ENTX - Earnings per share growth rate in current year|Earnings per share growth in current year MindWalk HYFT|Expected net earnings per share growth this year ABVC BioPharma, Inc (ABVC)|Cumberland Pharmaceuticals - Earnings growth in current year|quantumbiopharma.com (QNTM) - Net earnings per share growth this year|FGEN: Earnings growth in current year|TELO - Expected net earnings per share growth this year|RANI (Rani Therapeutics Holdings) - Earnings growth in current year|Earnings per share growth rate in current year Synergy CHC Corporation SNYR|Earnings per share growth in current year Rallybio Corporation (RLYB)|lexariabioscience.com - Earnings per share growth this year|Earnings growth in current year PULM (Pulmatrix)|PTHL - Net earnings per share growth this year|Aptorum - Earnings growth in current year|Earnings per share growth rate in current year Lyra Therapeutics Inc|Impact BioMedical (IBO) - Earnings per share growth in current year|TNFA - Expected net earnings per share growth this year|Earnings per share growth in current year cbdMD Inc.|PainReform Ltd - Earnings per share trend in current year|Earnings growth in current year CYTO|Net earnings per share growth this year Lipella Pharma LIPO|Earnings per share growth in current year OptiNose, Inc. OPTN|Earnings per share increase in current year PIRS|PROC: Net earnings per share growth this year|PTPI (Petros Pharmaceuticals Inc) - Earnings per share growth this year|Qilian International Holding Group Limited (QLI) - Earnings per share growth in current year|Earnings per share trend in current year SLRN (ACELYRIN Inc.)|TFFP (TFF Pharmaceuticals) - Earnings growth in current year
